Senior Lecturer and Honorary Consultant in Medical Oncology at Guy’s and St Thomas’ NHS Foundation Trust, and King’s College Hospital NHS Foundation Trust.
Dr Sarker graduated in medicine from the University of Liverpool in 1997, and subsequently trained in internal medicine and medical oncology. In 2003 he was appointed to a Cancer Research UK clinical research fellowship in the drug development unit of The Royal Marsden Hospital and Institute of Cancer Research, which led to the award of a PhD. He completed specialist training in medical oncology at The Royal Marsden in 2010, and was subsequently appointed to his new post as clinical senior lecturer in medical oncology at King’s.
Dr Sarker's research focus is in the development of novel therapies for cancer, and together with Professor James Spicer, runs the early phase clinical trials unit based at Guy’s Hospital. He has a particular interest in the development of signal transduction inhibitors, and the application of novel predictive and pharmacodynamic biomarkers, especially using molecular imaging. He is also actively involved in the management of hepato-pancreatic-biliary malignancies at both Guy's and King's College Hospital liver unit, and has a specific interest in the development of new therapies and molecular imaging for these tumours.
Dr Helen Mackie
Chief of Medical Services at NHS Lanarkshire 2014 - 2017 and a consultant Gastroenterologist since 2000. She is a part of the Realistic Medicine Team alongside Dr Catherine Calderwood, Chief Medical Officer for Scotland. Realistic Medicine aims to improve healthcare and manage risk better to reduce harm by acknowledging that a more personalised approach to patient care is needed.
Professor Jeff Evans
Professor Jeff Evans is a Group Leader (Translational Cancer Therapeutics Laboratory) at the CR-UK Beatson Institute, Glasgow, Professor of Translational Cancer Research and Director of the Institute of Cancer Sciences, University of Glasgow, and Honorary Consultant in Medical Oncology at the Beatson West of Scotland Cancer Centre, Glasgow, and Lead of the Glasgow Experimental Cancer Medicine Centre (ECMC).
His research interests are in the pre-clinical and clinical development of novel anti-cancer agents, and his clinical interests are in Upper GI Cancers and melanoma. He leads the Phase I clinical trials and drug development team in Glasgow, and is one of the co-leads of the PRECISION-Panc initiative.
He is a member of the NCRN Upper GI Cancer Pancreatic Cancer and Gastro-Oesophageal Cancer sub-groups, member of the ECMC – Industry Combinations Alliance Joint Steering Committee, member of CR-UK’s Clinical Experts Review Panel, and former member of Cancer Research UK’s New Agents Committee. He is co-editor of the clinical research section of the British Journal of Cancer.
Dr Ed Smith
Clinical Lead for Proton Beam Therapy Development at The Christie, Teenage and Young Adult Survivorship Lead, and chair of the Clinical Research and Effectiveness Committee. He is also a member of National Proton Therapy Panel and trustee of the Cyclotron Trust.
Professor Colin Watts
Professor Colin Watts leads the newly established Brain Cancer Program at the University of Birmingham. His research aims to improve the treatment and survival of patients with glioma by understanding the molecular genetic heterogeneity of individual tumours and using that data to develop novel molecular and functional stratification suitable for application in clinical trials. His clinical practice specializes in neurosurgical oncology with a particular interest in intrinsic gliomas and cerebral metastases. He has published over 160 papers, articles, book chapters and reviews and serves on the editorial boards of Neuro-oncology and the European Journal of Surgical Oncology.
As a practicing neurosurgeon Professor Watts has established a dedicated neurosurgical-oncology research clinic to support clinical trials and collaborative translational research. Ongoing clinical research include the GALA-BIDD trial looking into the utility of fluorescence-guided techniques to optimize cytoreduction, develop surgical biomarkers of high-grade cancer, and enhance post-operative management of glioma patients through accelerated molecular stratification.
Mr Bassam Alkari
Mr Alkari is a Consultant HPB Surgeon and a Senior Lecturer at the University of Aberdeen. He specialises in complex liver, pancreas and bile duct diseases with a specialist interest in advanced laparoscopic surgical techniques. Mr Alkari is also the Clinical Lead for Laparoscopic Spleen Surgery in collaboration with the Haematology Department in Aberdeen.
Mr Alkari has got a special interest in education and training for undergraduates and postgraduates at local, national and international level. He holds a role of Clinical and Educational Supervisor for post-graduate Surgical Trainees. He has published two Chapters in Journals focussed on post-graduate education and is also an examiner for the Royal College of Surgeons of Edinburgh.
Mr Alkari has published peer-reviewed articles pertaining to Specialist Laparoscopic Liver and Pancreatic Surgery and has presented at several national and international conferences. He is actively involved in clinical research and is the Primary Investigator of two large multi-centre trials looking at the detection and management of pancreatic cancer.